Noncoding RNA regulation of the human placental transcriptome among the sexes
Noncoding RNA regulation of the human placental transcriptome among the sexes
批准号:
9308742
负责人:
Margareta Pisarska
金额:
$45.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-10 至 2019-02-28
关键词:
AffectApoptosisBioinformaticsBlood CirculationChorionChorionic villiCodeCytogenetic AnalysisDevelopmentDiagnostic testsDiseaseFemaleFetal DevelopmentFetal DiseasesFetusFirst Pregnancy TrimesterFreezingFutureGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomicsGoalsHealthHumanIndividualLeadMaternal HealthModernizationMolecularOrganPlacentaPlacentationPlasmaPregnancyPrimigraviditiesRNARegulationRoleSamplingSex CharacteristicsSex ChromosomesSourceStatistical MethodsTechniquesTechnologyTestingThird Pregnancy TrimesterUntranslated RNAVillusautosomebiobankcell motilitydifferential expressionepigenomicsfetalin uteromalemultiple omicssexsexual dimorphismtranscriptometranscriptome sequencingtranscriptomicstrophoblast
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The placenta, critical for fetal health and development and a potential marker of maternal health, is poorly
understood. Traditionally, studies of human placental function have focused on samples obtained at term,
limiting our ability to understand both normal placental development and function throughout human
gestation. The development of conditions and diseases which manifest throughout pregnancy attributed to
placental development and subsequently function most likely occur early in gestation. Early direct placental
assessment can be achieved through chorionic villus sampling (CVS), performed in the late first trimester.
These villi, used for cytogenetic testing, also represent a unique window into the developing placenta. We
developed techniques to bank unused villi for use in subsequent multiple –omics testing including genomics,
epigenomics and transcriptomics and also collect term placental samples from these pregnancies providing
a window into placental development and potential function throughout gestation. Recently, we identified sex
differences in a number of genes expressed on autosomes and sex chromosomes in the first trimester
placenta, unique from those identified at term, suggesting there are sex differences in placental development
as early as the first trimester. In addition, we also identified differences in noncoding RNA fractions among
the sexes, expressed from both autosomes and sex chromosomes. As these noncoding RNA’s are important
regulators of transcriptional activity and hence overall function, they may explain the more subtle sex
differences observed in fetal development and disease as a result of placental development. However, sexual
dimorphism of gene regulation through noncoding RNA has not been studied in normal placental
development. Thus, using our already stored samples and our genomics bioinformatics expertise, we have
the opportunity to better understand the role of these noncoding RNAs on RNA regulation in placental
development throughout gestation among the sexes. In addition, we have corresponding banked maternal
plasma from pregnancies in which villi are banked. We have recently isolated placental RNA from our stored
samples and intend to use these samples to identify key markers of placental function that are reflective of
the intrauterine placenta. Thus, we intend to use our established banked first trimester and term placental
samples to establish a normative and sexually distinct placental signature of total RNA (noncoding and coding)
throughout gestation. We also intend to identify functional activity of noncoding RNAs on placental function
followed by the development of a functionally relevant signature that can be identified in the maternal circulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of sex and gender on disease progression, from developmental origins
-
批准号:10469623
-
项目类别:
-
资助金额:$57.05万
-
财政年份:2020
-
负责人:Margareta Pisarska
-
依托单位:
The impact of sex and gender on disease progression, from developmental origins
-
批准号:10687088
-
项目类别:
-
资助金额:$13.99万
-
财政年份:2020
-
负责人:Margareta Pisarska
-
依托单位:
The impact of sex and gender on disease progression, from developmental origins
-
批准号:10062754
-
项目类别:
-
资助金额:$57.66万
-
财政年份:2020
-
负责人:Margareta Pisarska
-
依托单位:
The impact of sex and gender on disease progression, from developmental origins
-
批准号:10260551
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2020
-
负责人:Margareta Pisarska
-
依托单位:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
-
批准号:10675005
-
项目类别:
-
资助金额:$79.3万
-
财政年份:2019
-
负责人:Margareta Pisarska
-
依托单位:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
-
批准号:10252913
-
项目类别:
-
资助金额:$77.72万
-
财政年份:2019
-
负责人:Margareta Pisarska
-
依托单位:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
-
批准号:8529827
-
项目类别:
-
资助金额:$61.9万
-
财政年份:2013
-
负责人:Margareta Pisarska
-
依托单位:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
-
批准号:9067824
-
项目类别:
-
资助金额:$79.34万
-
财政年份:2013
-
负责人:Margareta Pisarska
-
依托单位:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
-
批准号:8735977
-
项目类别:
-
资助金额:$65.06万
-
财政年份:2013
-
负责人:Margareta Pisarska
-
依托单位:
Effects of fetal sex on the first trimester transcriptome
-
批准号:8994647
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2013
-
负责人:Margareta Pisarska
-
依托单位:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
-
批准号:8848413
-
项目类别:
-
资助金额:$64.99万
-
财政年份:2013
-
负责人:Margareta Pisarska
-
依托单位:
Molecular Mechanisms of FOXL2, An Ovarian Failure Gene
-
批准号:8097122
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2010
-
负责人:Margareta Pisarska
-
依托单位:
Molecular Mechanisms of FOXL2, An Ovarian Failure Gene
-
批准号:7289689
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2006
-
负责人:Margareta Pisarska
-
依托单位:
Molecular Mechanisms of FOXL2, An Ovarian Failure Gene
-
批准号:7145890
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2006
-
负责人:Margareta Pisarska
-
依托单位:
Molecular Mechanisms of FOXL2, An Ovarian Failure Gene
-
批准号:7882563
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2006
-
负责人:Margareta Pisarska
-
依托单位:
Molecular Mechanisms of FOXL2, An Ovarian Failure Gene
-
批准号:7501420
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2006
-
负责人:Margareta Pisarska
-
依托单位:
Molecular Mechanisms of FOXL2, An Ovarian Failure Gene
-
批准号:7655407
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2006
-
负责人:Margareta Pisarska
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: